课题基金 / 基金详情

CD4 AND CORECEPTORS IN HIV-1/AIDS

CD4 AND CORECEPTORS IN HIV-1/AIDS
HIV-1/AIDS 中的 CD4 和辅助受体
批准号:
6489237
负责人:
David Kabat
金额:
$27.61万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-03-15 至 2003-12-31

项目摘要

项目成果

David Kabat的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from investigator's abstract) The goal of this project is to analyze quantitatively infections by primary patient (PR) and laboratory-adapted (LA) isolate viruses and to learn how differences in CD4 affinities affect cellular tropisms. The first of the investigator's three specific aims is to study quantitatively adsorption and penetration of PR and LA T cell-tropic HIV isolates into CD4- positive cells using cell clones with diverse amounts of CD4. The author proposes to study the kinetics of the steps of HIV attachment and to determine the order of CD4 involvement in each step. He will identify cellular factor(s) other than CD4 that limit attachment of LA viruses and their placement in the infection pathway. The second aim is to use molecularly cloned env genes of PR and LA viruses and of mutant viruses that have reduced CD4 affinities, and to identify features of env glycoproteins that control discrete steps of viral entry pathways. The third aim is to learn how absorptive properties of PR viruses change throughout disease progression. The fourth and last aim is to develop a novel system to study gp120- gp41- and CD4-dependent cell-cell fusion and to use it to study and possibly to clone cDNAs for cellular accessory factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug development for Vif-APOBEC3G in HIV-1/AIDS
Drug development for Vif-APOBEC3G in HIV-1/AIDS
Drug development for Vif-APOBEC3G in HIV-1/AIDS
Role of Vif in HIV-1 Replication/AIDS
海外基金